Publication:
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS

dc.contributor.authorMoreau, Philippe
dc.contributor.authorChari, Ajai
dc.contributor.authorOriol, Albert
dc.contributor.authorMartinez-Lopez, Joaquin
dc.contributor.authorHaenel, Mathias
dc.contributor.authorTouzeau, Cyrille
dc.contributor.authorAilawadhi, Sikander
dc.contributor.authorBesemer, Britta
dc.contributor.authorde la Rubia Comos, Javier
dc.contributor.authorEncinas, Cristina
dc.contributor.authorMateos, Maria-Victoria
dc.contributor.authorSalwender, Hans
dc.contributor.authorRodriguez-Otero, Paula
dc.contributor.authorHulin, Cyrille
dc.contributor.authorKarlin, Lionel
dc.contributor.authorSureda, Anna
dc.contributor.authorBargay Lleonart, Joan
dc.contributor.authorBenboubker, Lotfi
dc.contributor.authorRosiñol, Laura
dc.contributor.authorTarantolo, Stefano
dc.contributor.authorTerebelo, Howard
dc.contributor.authorYang, Shiyi
dc.contributor.authorWang, Jing Jing
dc.contributor.authorNnane, Ivo
dc.contributor.authorQi, Ming
dc.contributor.authorKosh, Michele
dc.contributor.authorDelioukina, Maria
dc.contributor.authorGoldschmidt, Hartmut
dc.contributor.authorMoreau, Philippe
dc.contributor.authorChari, Ajai
dc.contributor.authorOriol, Albert
dc.contributor.authorMartinez-Lopez, Joaquin
dc.contributor.authorHaenel, Mathias
dc.contributor.authorTouzeau, Cyrille
dc.contributor.authorAilawadhi, Sikander
dc.contributor.authorBesemer, Britta
dc.contributor.authorde la Rubia Comos, Javier
dc.contributor.authorEncinas, Cristina
dc.contributor.authorMateos, Maria-Victoria
dc.contributor.authorSalwender, Hans
dc.contributor.authorRodriguez-Otero, Paula
dc.contributor.authorHulin, Cyrille
dc.contributor.authorKarlin, Lionel
dc.contributor.authorSureda, Anna
dc.contributor.authorBargay Lleonart, Joan
dc.contributor.authorBenboubker, Lotfi
dc.contributor.authorRosiñol, Laura
dc.contributor.authorTarantolo, Stefano
dc.contributor.authorTerebelo, Howard
dc.contributor.authorYang, Shiyi
dc.contributor.authorWang, Jing Jing
dc.contributor.authorNnane, Ivo
dc.contributor.authorQi, Ming
dc.contributor.authorKosh, Michele
dc.contributor.authorDelioukina, Maria
dc.contributor.authorGoldschmidt, Hartmut
dc.date.accessioned2024-10-09T06:33:50Z
dc.date.available2024-10-09T06:33:50Z
dc.date.issued2023-03-07
dc.format.number1es_ES
dc.format.page33es_ES
dc.format.volume13es_ES
dc.identifier.citationMoreau P, Chari A, Oriol A, Martinez-Lopez J, Haenel M, Touzeau C, et al. Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood Cancer J. 2023 Mar 7;13(1):33.en
dc.identifier.doi10.1038/s41408-023-00805-x
dc.identifier.e-issn2044-5385es_ES
dc.identifier.journalBlood cancer journales_ES
dc.identifier.otherhttps://hdl.handle.net/20.500.13003/18923
dc.identifier.pubmedID36882409es_ES
dc.identifier.puiL2021978120
dc.identifier.scopus2-s2.0-85149595607
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23626
dc.identifier.wos950825100001
dc.language.isoengen
dc.publisherSpringer
dc.relation.publisherversionhttps://doi.org/10.1038/s41408-023-00805-xen
dc.repisalud.instituteIIS::IiSGM - Instituto de Investigación Sanitaria Gregorio Marañón (Madrid)
dc.rights.accessRightsopen accessen
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.decsDexametasona*
dc.subject.decsHumanos*
dc.subject.decsNeoplasias de Células Plasmáticas*
dc.subject.decsMieloma Múltiple*
dc.subject.decsAnticuerpos Monoclonales*
dc.subject.meshMultiple Myeloma*
dc.subject.meshAntibodies, Monoclonal*
dc.subject.meshHumans*
dc.subject.meshNeoplasms, Plasma Cell*
dc.subject.meshDexamethasone*
dc.titleDaratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUSen
dc.typeletter to the editoren
dspace.entity.typePublication
relation.isAuthorOfPublication9b25aa8e-597b-43e0-90d0-6d3846974c12
relation.isAuthorOfPublication.latestForDiscovery9b25aa8e-597b-43e0-90d0-6d3846974c12
relation.isPublisherOfPublication8d558850-2ef2-4d1e-b0e1-4e5591ab6288
relation.isPublisherOfPublication.latestForDiscovery8d558850-2ef2-4d1e-b0e1-4e5591ab6288

Files